Clinical Trial

Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

Study acronym: TIPITCH
Recruiting
View on ClinicalTrials.gov →
Summary
This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected. The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study. The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-05-07
notable Primary completion pushed: 2036-02 -> 2036-04 2026-05-07
minor Completion pushed: 2036-02 -> 2036-04 2026-05-07
Trial Details
NCT Number NCT07444853
Lead Sponsor University Hospital, Tours
Conditions Intracerebral Hemorrhage (ICH)
Enrollment 10,000 participants
Start Date 2026-04-09
Primary Completion 2036-04 (estimated)
Study Completion 2036-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-06